a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying our deep knowledge of translational bioinformatics to every stage of the drug development process.
Lead Underwriter
Cowen and Company, LLC, Guggenheim Securities, LLC, Jefferies LLC, Morgan Stanley & Co. LLC
